Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip A Harris

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Expert Opinion on Therapeutic Patents|November 30, 2020
Inhibitors of RIP1 kinase: a patent review (2016-present)Philip A Harris
Bioorganic & Medicinal Chemistry Letters|August 24, 2015
Recent progress on MAP kinase pathway inhibitorsDavid E Uehling, Philip A Harris
Pediatric Surgery International|November 5, 2002
Sporadic aplasia cutis congenitaLinda-Lynn Fagan, Philip A Harris, Arnold G Coran, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
N'-[1-(2,4-Dioxo-3,4-dihydro-2H-1-benzopyran-3-yl-idene)eth-yl]thiophene-2-carbo-hydrazideMadeleine Helliwell, Despina A Nasiopoulou, Philip A Harris, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindolesEdgar R Wood, Lee Kuyper, Kimberly G Petrov, et al.
Molecules (Basel, Switzerland)|January 26, 2016
Antioxidant Activity of 3-[N-(Acylhydrazono)ethyl]-4-hydroxy-coumarinsAntigoni Kotali, Despina A Nasiopoulou, Constantinos A Tsoleridis, et al.
Cell Host & Microbe|February 13, 2015
Herpes simplex virus suppresses necroptosis in human cellsHongyan Guo, Shinya Omoto, Philip A Harris, et al.
Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.
Organic Letters|October 8, 2005
Pyrazolo[1,5-a]pyridines as p38 kinase inhibitorsKirk L Stevens, David K Jung, Michael J Alberti, et al.
Journal of Medicinal Chemistry|August 7, 2007
Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptorsMasaichi Hasegawa, Naohiko Nishigaki, Yoshiaki Washio, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|November 30, 2020
Inhibitors of RIP1 kinase: a patent review (2016-present)Philip A Harris
Bioorganic & Medicinal Chemistry Letters|August 24, 2015
Recent progress on MAP kinase pathway inhibitorsDavid E Uehling, Philip A Harris
Pediatric Surgery International|November 5, 2002
Sporadic aplasia cutis congenitaLinda-Lynn Fagan, Philip A Harris, Arnold G Coran, et al.
Acta Crystallographica. Section E, Structure Reports Online|July 15, 2011
N'-[1-(2,4-Dioxo-3,4-dihydro-2H-1-benzopyran-3-yl-idene)eth-yl]thiophene-2-carbo-hydrazideMadeleine Helliwell, Despina A Nasiopoulou, Philip A Harris, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
Discovery and in vitro evaluation of potent TrkA kinase inhibitors: oxindole and aza-oxindolesEdgar R Wood, Lee Kuyper, Kimberly G Petrov, et al.
Molecules (Basel, Switzerland)|January 26, 2016
Antioxidant Activity of 3-[N-(Acylhydrazono)ethyl]-4-hydroxy-coumarinsAntigoni Kotali, Despina A Nasiopoulou, Constantinos A Tsoleridis, et al.
Cell Host & Microbe|February 13, 2015
Herpes simplex virus suppresses necroptosis in human cellsHongyan Guo, Shinya Omoto, Philip A Harris, et al.
Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.
Organic Letters|October 8, 2005
Pyrazolo[1,5-a]pyridines as p38 kinase inhibitorsKirk L Stevens, David K Jung, Michael J Alberti, et al.
Journal of Medicinal Chemistry|August 7, 2007
Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptorsMasaichi Hasegawa, Naohiko Nishigaki, Yoshiaki Washio, et al.
Pageof 3